Absolute numbers of lives saved and overdiagnosis in breast cancer screening, from a randomized trial and from the Breast Screening Programme in England
about
Implications of Overdiagnosis: Impact on Screening Mammography PracticesQuantifying and monitoring overdiagnosis in cancer screening: a systematic review of methodsCancer screening in the United States, 2013: a review of current American Cancer Society guidelines, current issues in cancer screening, and new guidance on cervical cancer screening and lung cancer screeningMammographic screening for breast cancer: A reviewScreening mammography--early detection or over-diagnosis? Contribution from Australian data.Commentary: Tempering expectations of screening: what is the most authoritative advice we can give, given the data that we have?Screening mammography & breast cancer mortality: meta-analysis of quasi-experimental studies.Modelling the overdiagnosis of breast cancer due to mammography screening in women aged 40 to 49 in the United KingdomPersonalised informed choice on evidence and controversy on mammography screening: study protocol for a randomized controlled trial.Benefit-to-harm ratio of the Danish breast cancer screening programme.Registry-based study of trends in breast cancer screening mammography before and after the 2009 U.S. Preventive Services Task Force recommendations.Interpreting overdiagnosis estimates in population-based mammography screeningLetter in response to "Cherry-picking of evidence fails to accurately show extent of overdiagnosis: Mammographic screening harms understated"Cherry-picking of evidence fails to accurately show extent of overdiagnosis: Mammographic screening harms understatedA pragmatic assessment of the relative efficiency of outreach chlamydia screening events conducted in non-clinical settings.Overdiagnosis due to breast cancer screening: updated estimates of the Helsinki service study in Finland.Polygenic susceptibility to prostate and breast cancer: implications for personalised screeningThe transplant patient and transplant medicine in family practiceAn ongoing case-control study to evaluate the NHS breast screening programme.Advantages and Disadvantages of Mammography ScreeningOverdiagnosis: epidemiologic concepts and estimation.Nonpalpable breast carcinomas: long-term evaluation of 1,258 cases.Adjusting the frequency of mammography screening on the basis of genetic risk: Attitudes among women in the UK.Possible net harms of breast cancer screening: updated modelling of Forrest report.A survey study of women's responses to information about overdiagnosis in breast cancer screening in Britain.Mammography screening in three Finnish residential areas: comprehensive population-based study of breast cancer incidence and incidence-based mortality 1976-2009.Beyond the mammography debate: a moderate perspectiveFraming overdiagnosis in breast screening: a qualitative study with Australian expertsA meta-analysis of mammographic screening with and without clinical breast examination.Effect of insurance status on the stage of breast and colorectal cancers in a safety-net hospital.The effect of DCIS grade on rate, type and time to recurrence after 15 years of follow-up of screen-detected DCIS.Information on 'Overdiagnosis' in Breast Cancer Screening on Prominent United Kingdom- and Australia-Oriented Health WebsitesThe dynamic optical breast imaging in the preoperative workflow of women with suspicious or malignant breast lesions: development of a new comprehensive scoreBreast screening review--a radiologist's perspective.Understanding the heterogeneity of cervical cancer screening non-participants: Data from a national sample of British women.Balancing harms and benefits of service mammography screening programs: a cohort study.Benefits and harms of mammography screening after age 74 years: model estimates of overdiagnosis.Women's responses to information about overdiagnosis in the UK breast cancer screening programme: a qualitative study.Economic analyses of breast cancer control in low- and middle-income countries: a systematic review.Overdiagnosis in breast cancer screening: the importance of length of observation period and lead time.
P2860
Q26785575-BB03B66D-C402-4FB5-ACEE-5C68D4DA6159Q26824867-AB97A14C-71E4-4238-9925-B4AC945EB11DQ26864419-69A3921E-46A1-43CF-9F57-563FA2E15801Q27006907-6994E8EA-BB2E-4626-8BA9-62E86F434864Q30851278-C799C94B-42D8-4F98-88D9-B594D38CA2DBQ30884774-77F553DF-97D5-4C25-908C-79CDC2D25F74Q33699944-4C486826-5E81-47C5-AB6D-FA2F7D54C2A9Q33739409-B2969707-DAAD-498E-978F-2569BA2E04D7Q33814877-C8379E29-E14F-4E4A-AC94-16F1B71E2641Q33845856-72476836-329C-41DF-8B3D-F66FD483179FQ33986348-4A9B5E07-A40A-4D7E-9492-8C489C9978A8Q34195837-66F84053-B922-47E1-9D30-2D31BBE554B3Q34247378-6A92D46D-0121-4D19-A4B0-DDE8FDE81F45Q34247393-74436BE4-C56F-4FA8-B5F2-66CB5A1B7924Q34263512-23E1EA40-8E50-4BD4-9685-E4280E4A1CEDQ34283688-E6B979DA-5E4E-4D39-B71D-66EF68346C36Q34977428-B118F2EF-0351-43AC-8685-2F636E689F62Q35029807-1AFD3F22-3607-4F59-B691-021D9216A2FEQ35065320-92FE921B-2353-4ADA-B300-EDB9E2F8DAB8Q35095608-ACA9AF98-2855-4E51-BEB2-1EA3099612EDQ35438645-C576B976-BB10-4D85-9690-0D1E7C30BFBBQ35583865-E751065A-0E93-4985-B1D4-0611DE0E0B7BQ35592936-CA177FC7-BDD1-464A-990C-90D2437C9CD3Q35603080-DFD2BD36-7668-42C3-9CC0-52DB54080C5EQ35678095-3F7E0A4B-11B0-49BF-ACCC-0C8BA7F2D919Q35678672-5A4CCB94-2F13-4A3A-AC0C-0A7735EA60BEQ35714557-1321C933-08ED-415E-8EE6-067ADC726A13Q35757874-928FFEC9-0C80-48F8-9E46-E4AA97BF1755Q35904185-B1A59728-2F3E-4B14-8996-AA46286BDD75Q35947725-9DDE9352-1D49-4868-8FF2-569BBDB5483EQ35949533-3D60D7EE-7B4E-4D08-B814-B0E699A66857Q35968854-5065D5EC-BBB6-4F21-B05A-A986B4A9D30DQ36307447-F042622A-2C97-4A48-9D5E-ABF83BAC0B31Q36326154-7137D134-ED8F-46EB-8D67-463FE5AE66F9Q36378664-EF3A1D03-CDDD-493F-8F8C-63D6D44250EDQ36393116-61B71363-4938-4A8E-93DE-2976D711BDC5Q36770273-433D6632-57E0-4861-8BCF-C44516F44243Q36809821-6F91D041-F141-43CA-84C9-0F9C43310E1EQ36835024-D0F83D25-27FE-458F-B09A-F3FFBF451529Q36998186-78D56083-7492-47A3-8007-26B5399BF204
P2860
Absolute numbers of lives saved and overdiagnosis in breast cancer screening, from a randomized trial and from the Breast Screening Programme in England
description
2010 nî lūn-bûn
@nan
2010 թուականին հրատարակուած գիտական յօդուած
@hyw
2010 թվականին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Absolute numbers of lives save ...... Screening Programme in England
@ast
Absolute numbers of lives save ...... Screening Programme in England
@en
Absolute numbers of lives save ...... Screening Programme in England
@nl
type
label
Absolute numbers of lives save ...... Screening Programme in England
@ast
Absolute numbers of lives save ...... Screening Programme in England
@en
Absolute numbers of lives save ...... Screening Programme in England
@nl
prefLabel
Absolute numbers of lives save ...... Screening Programme in England
@ast
Absolute numbers of lives save ...... Screening Programme in England
@en
Absolute numbers of lives save ...... Screening Programme in England
@nl
P2093
P2860
P3181
P356
P1476
Absolute numbers of lives save ...... Screening Programme in England
@en
P2093
Amy M F Yen
Anne Helene Olsen
Bedrich Vitak
Laszlo Tabar
Prue C Allgood
Robert A Smith
Stephen W Duffy
P2860
P3181
P356
10.1258/JMS.2009.009094
P407
P577
2010-01-01T00:00:00Z